Fuelling implant efficiency

Researchers at Newcastle University are investigating the use of substances contained in the bloodstream as a means of producing long-life, low-power fuel cells that can be implanted into the body.

Researchers at Newcastle University are investigating the use of substances contained in the bloodstream as a means of producing long-life, low-power fuel cells that can be implanted into the body.

The ‘biofuel’ cells could be used in devices such as pacemakers, insulin pumps and prosthetic units. To keep up with the advances being made in medicine and the ever-increasing number of implantable devices used in operations, there is a growing need for miniature low-power sources to run the implants safely.

Chris Jones, research associate at the university, said biofuel technology is an as yet untapped market.

‘There are many benefits to using biofuel cells, particularly in surgery, one of the main being that you can introduce them into the body without having to use any toxic or foreign materials. We are using elements that are already present in the body such as glucose and oxygen.’

The research will investigate new ways of immobilising enzymes on to electrode substrates, as well as the development of fuel systems using nano-carbons and membrane-less fuel cells.

Register now to continue reading

Thanks for visiting The Engineer. You’ve now reached your monthly limit of news stories. Register for free to unlock unlimited access to all of our news coverage, as well as premium content including opinion, in-depth features and special reports.  

Benefits of registering

  • In-depth insights and coverage of key emerging trends

  • Unrestricted access to special reports throughout the year

  • Daily technology news delivered straight to your inbox